Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
3.990
+0.140 (3.64%)
At close: Feb 12, 2026, 4:00 PM EST
3.990
0.00 (0.00%)
After-hours: Feb 12, 2026, 4:10 PM EST
Artiva Biotherapeutics Market Cap
Artiva Biotherapeutics has a market cap or net worth of $97.93 million as of February 12, 2026. Its market cap has decreased by -25.06% in one year.
Market Cap
97.93M
Enterprise Value
-16.78M
1-Year Change
-25.06%
Ranking
Category
Stock Price
$3.99
Market Cap Chart
Since the IPO on July 19, 2024, Artiva Biotherapeutics's market cap has decreased from $176.76M to $97.93M, a decrease of -44.59%. That is a compound annual growth rate of -31.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 97.93M | -6.99% |
| Dec 31, 2025 | 105.30M | -56.99% |
| Dec 31, 2024 | 244.84M | 38.52% |
| Jul 19, 2024 | 176.76M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cognition Therapeutics | 100.63M |
| Vivani Medical | 100.62M |
| Seer, Inc. | 99.57M |
| Actuate Therapeutics | 99.25M |
| Anixa Biosciences | 99.14M |
| Dogwood Therapeutics | 96.89M |
| Verrica Pharmaceuticals | 96.42M |
| Immunic | 95.59M |